Komori
S&B Foods (2805) · InitiativeRestated

Research on the Safety, Stable Supply and Functionality of Spices and Herbs

First written in FY2016. 27 of 29 entries say "Restated". Latest entry: 2026-10-30.

29entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2021-Q3RestatedFY2022-Q1 – 2026-10-302016: 220162017: 320172018: 420182019: 320192020: 320202021: 420212022: 420222023: 220232024: 220242025: 120252026: 12026
Same theme, other companies

The whole theme swung hardest in 2022: 1 of 8 companies on the "Worse" side.

2 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. 2026-10-30RestatedRevisions to earnings forecasts

    「During the interim consolidated accounting period, we implemented measures for sustainable growth and higher corporate value based on the Fourth Medium-Term Management Plan, including strengthening the overseas business and continuing research and development relating to spices and herbs, and advanced initiatives to continue creating new value.」

    The company has reaffirmed its continuing research and development relating to spices and herbs as a measure under the Fourth Medium-Term Management Plan.
  2. FY2026-H1RestatedAnnual report

    「The total research and development expenses of the Group for the cumulative interim consolidated period were ¥729 million. There were no material changes in the status of the Group’s research and development activities during the cumulative interim consolidated period.」

    The company disclosed cumulative interim research and development expenses of ¥729 million and stated that there were no material changes in its research and development activities.
  3. FY2024RestatedAnnual report

    「For spices and herbs, the primary raw materials, the company is working to ensure safety and security and maintain a stable, sustainable supply, and is also conducting research into residue pesticide analysis, breeding and cultivation technologies, aroma analysis for quality evaluation and the superior functionality that has attracted attention in recent years.」

    The company continues to conduct residue pesticide analysis, research into breeding and cultivation technologies, aroma analysis and functionality research, and total research and development expenses were ¥1,335 million.
  4. FY2024-Q3RestatedAnnual report

    「The total research and development expenses of the Group for the cumulative third quarter ended during the current consolidated fiscal year were ¥985 million. By segment, research and development expenses were ¥883 million for the Food Products business and ¥101 million for Prepared Foods. There were no material changes in the status of the Group’s research and development activities during the cumulative third quarter ended during the current consolidated fiscal year.」

    The company disclosed cumulative nine-month research and development expenses of ¥985 million and stated that there were no material changes in its research and development activities.
  5. FY2024-Q2RestatedAnnual report

    「The total research and development expenses of the Group for the cumulative second quarter ended during the current consolidated fiscal year were ¥656 million. By segment, research and development expenses were ¥589 million for the Food Products business and ¥67 million for Prepared Foods. There were no material changes in the status of the Group’s research and development activities during the cumulative second quarter ended during the current consolidated fiscal year.」

    The company disclosed cumulative first-half research and development expenses of ¥656 million and stated that there were no material changes in its research and development activities.
  6. FY2023-Q3RestatedAnnual report

    「The Group’s total research and development expenses for the nine months ended the third quarter amounted to ¥1,007 million. By segment, research and development expenses were ¥899 million for the Food Products business and ¥108 million for Prepared Foods. There were no material changes in the status of the Group’s research and development activities during the nine months ended the third quarter.」

    The company disclosed that there were no material changes in its research and development activities, including research on the safety, stable supply, quality, functionality and other aspects of spices and herbs.
  7. FY2023-Q2RestatedAnnual report

    「The Group’s total research and development expenses for the six months ended the second quarter amounted to ¥657 million. By segment, research and development expenses were ¥587 million for the Food Products business and ¥70 million for Prepared Foods. There were no material changes in the status of the Group’s research and development activities during the six months ended the second quarter.」

    The company disclosed that there were no material changes in its research and development activities, including research on the safety, stable supply, quality and functionality of spices and herbs.
  8. FY2023-Q1RestatedAnnual report

    「The total research and development expenses of the Group for the cumulative first quarter ended during the current consolidated fiscal year were ¥315 million. By segment, research and development expenses were ¥285 million for the Food Products business and ¥29 million for Prepared Foods. There were no material changes in the status of the Group’s research and development activities during the cumulative first quarter ended during the current consolidated fiscal year.」

    The company disclosed that there were no material changes in its research and development activities and that cumulative first-quarter research and development expenses were ¥315 million.
  9. FY2022RestatedAnnual report

    「For spices and herbs, the primary raw materials, the company is working to ensure safety and security and maintain a stable supply, and is also conducting research into residue pesticide analysis, breeding and cultivation technologies, aroma analysis for quality evaluation and the superior functionality that has attracted attention in recent years.」

    The company continues to conduct research on the safety, stable supply, quality and functionality of spices and herbs, and total research and development expenses were ¥1,264 million.
  10. FY2022-Q3RestatedAnnual report

    「The total research and development expenses of the Group for the cumulative third quarter ended during the current consolidated fiscal year were ¥937 million. By segment, research and development expenses were ¥832 million for the Food Products business and ¥105 million for Prepared Foods. There were no material changes in the status of the Group’s research and development activities during the cumulative third quarter ended during the current consolidated fiscal year.」

    The company disclosed that there were no material changes in its research and development activities and that cumulative nine-month research and development expenses were ¥937 million.
  11. FY2022-Q2RestatedAnnual report

    「The total research and development expenses of the Group for the cumulative second quarter ended during the current consolidated fiscal year were ¥629 million. By segment, research and development expenses were ¥561 million for the Food Products business and ¥68 million for Prepared Foods. There were no material changes in the status of the Group’s research and development activities during the cumulative second quarter ended during the current consolidated fiscal year.」

    The company disclosed that there were no material changes in its research and development activities and that cumulative first-half research and development expenses were ¥629 million.
  12. FY2022-Q1RestatedAnnual report

    「The total research and development expenses of the Group for the cumulative first quarter ended during the current consolidated fiscal year were ¥315 million. By segment, research and development expenses were ¥286 million for the Food Products business and ¥28 million for Prepared Foods. There were no material changes in the status of the Group’s research and development activities during the cumulative first quarter ended during the current consolidated fiscal year.」

    The company disclosed that there were no material changes in its research and development activities and that cumulative first-quarter research and development expenses were ¥315 million.
  13. FY2021AdvancedAnnual report

    「For spices and herbs, the primary raw materials, the company is working to ensure safety and security and maintain a stable supply, and is also conducting research into residue pesticide analysis, breeding and cultivation technologies, aroma analysis for quality evaluation and the superior functionality that has attracted attention in recent years. It is also conducting research into food processing technologies, containers and packaging, and microbial control and management technologies in order to develop products that meet customers’ diverse needs.」

    In addition to its existing research on raw material safety, stable supply and functionality, the company specified research into food processing, containers and packaging, and microbial control and management technologies, and research and development expenses were ¥1,208 million.
  14. FY2021-Q3RestatedAnnual report

    「The total research and development expenses of the Group for the cumulative third quarter ended during the current consolidated fiscal year were ¥883 million. By segment, research and development expenses were ¥783 million for the Food Products business and ¥99 million for Prepared Foods. There were no material changes in the status of the Group’s research and development activities during the cumulative third quarter ended during the current consolidated fiscal year.」

    The company stated that there were no material changes in its research and development activities and reported cumulative nine-month research and development expenses of ¥883 million.
  15. FY2021-Q2RestatedAnnual report

    「The total research and development expenses of the Group for the cumulative second quarter ended during the current consolidated fiscal year were ¥551 million. By segment, research and development expenses were ¥487 million for the Food Products business and ¥64 million for Prepared Foods. There were no material changes in the status of the Group’s research and development activities during the cumulative second quarter ended during the current consolidated fiscal year.」

    The company stated that there were no material changes in its research and development activities and reported cumulative first-half research and development expenses of ¥551 million.
  16. FY2020RestatedAnnual report

    「For spices and herbs, the primary raw materials, the company is working to ensure safety and security and maintain a stable supply, and is also conducting research into residue pesticide analysis, breeding and cultivation technologies, aroma analysis for quality evaluation and the superior functionality that has attracted attention in recent years.」

    The company continues to conduct research on the safety, stable supply, quality and functionality of spices and herbs, and total research and development expenses were ¥1,131 million.
  17. FY2020-Q3RestatedAnnual report

    「The total research and development expenses of the Group for the cumulative third quarter ended during the current consolidated fiscal year were ¥813 million. By segment, research and development expenses were ¥663 million for the Food Products business and ¥149 million for Prepared Foods. There were no material changes in the status of the Group’s research and development activities during the cumulative third quarter ended during the current consolidated fiscal year.」

    The company stated that there were no material changes in its research and development activities and reported cumulative nine-month research and development expenses of ¥813 million.
  18. FY2020-Q1RestatedAnnual report

    「The total research and development expenses of the Group for the cumulative first quarter ended during the current consolidated fiscal year were ¥230 million. By segment, research and development expenses were ¥187 million for the Food Products business and ¥43 million for Prepared Foods. There were no material changes in the status of the Group’s research and development activities during the cumulative first quarter ended during the current consolidated fiscal year.」

    The company stated that first-quarter research and development expenses were ¥230 million and that there were no material changes in the status of its research and development activities.
  19. FY2019RestatedAnnual report

    「For spices and herbs, the primary raw materials, the company is working to ensure safety and security and maintain a stable supply, and is also conducting research into residue pesticide analysis, breeding and cultivation technologies, aroma analysis for quality evaluation and the superior functionality that has attracted attention in recent years.」

    The company continues to conduct residue pesticide analysis, research into breeding and cultivation technologies, aroma analysis and functionality research. Total research and development expenses were ¥1,023 million.
  20. FY2019-Q3RestatedAnnual report

    「The total research and development expenses of the Group for the cumulative third quarter ended during the current consolidated fiscal year were ¥741 million. By segment, research and development expenses were ¥593 million for the Food Products business and ¥148 million for Prepared Foods. There were no material changes in the status of the Group’s research and development activities during the cumulative third quarter ended during the current consolidated fiscal year.」

    The company stated that there were no material changes in its research and development activities and reported cumulative nine-month research and development expenses of ¥741 million.
  21. FY2019-Q2RestatedAnnual report

    「The total research and development expenses of the Group for the cumulative second quarter ended during the current consolidated fiscal year were ¥483 million. By segment, research and development expenses were ¥391 million for the Food Products business and ¥91 million for Prepared Foods. There were no material changes in the status of the Group’s research and development activities during the cumulative second quarter ended during the current consolidated fiscal year.」

    The company stated that there were no material changes in its research and development activities and reported cumulative first-half research and development expenses of ¥483 million.
  22. FY2019-Q1RestatedAnnual report

    「The total research and development expenses of the Group for the cumulative first quarter ended during the current consolidated fiscal year were ¥230 million. By segment, research and development expenses were ¥191 million for the Food Products business and ¥38 million for Prepared Foods. There were no material changes in the status of the Group’s research and development activities during the cumulative first quarter ended during the current consolidated fiscal year.」

    The company stated that there were no material changes in its research and development activities and reported cumulative first-quarter research and development expenses of ¥230 million.
  23. FY2018RestatedAnnual report

    「For spices and herbs, the primary raw materials, the company is working to improve and refine quality through residue pesticide analysis and research into breeding and cultivation technologies, with the aim of further ensuring safety and security and maintaining a stable supply. It is also conducting aroma analysis for quality evaluation and research into the superior functionality that has attracted attention in recent years.」

    The company continues to conduct research on the safety, stable supply, quality and functionality of spices and herbs, and research and development expenses for the consolidated fiscal year were ¥932 million.
  24. FY2018-Q3RestatedAnnual report

    「The total research and development expenses of the Group for the cumulative third quarter ended during the current consolidated fiscal year were ¥697 million. By segment, research and development expenses were ¥545 million for the Food Products business and ¥151 million for Prepared Foods. There were no material changes in the status of the Group’s research and development activities during the cumulative third quarter ended during the current consolidated fiscal year.」

    The company stated that there were no material changes in its research and development activities and reported cumulative nine-month research and development expenses of ¥697 million.
  25. FY2018-Q2RestatedAnnual report

    「The total research and development expenses of the Group for the cumulative second quarter ended during the current consolidated fiscal year were ¥454 million. By segment, research and development expenses were ¥357 million for the Food Products business and ¥96 million for Prepared Foods. There were no material changes in the status of the Group’s research and development activities during the cumulative second quarter ended during the current consolidated fiscal year.」

    The company stated that there were no material changes in its research and development activities and reported cumulative first-half research and development expenses of ¥454 million.
  26. FY2017RestatedAnnual report

    「For spices and herbs, the primary raw materials, the company is working to improve and refine quality through genetic-level analysis and research into breeding and cultivation technologies, with the aim of further ensuring safety and security and maintaining a stable supply.」

    The company continues to conduct research on the safety, stable supply, quality improvement and functionality of spices and herbs.
  27. FY2017-Q3RestatedAnnual report

    「The total research and development expenses of the Group for the cumulative third quarter ended during the current consolidated fiscal year were ¥693 million. By segment, research and development expenses were ¥548 million for the Food Products business and ¥145 million for Prepared Foods. There were no material changes in the status of the Group’s research and development activities during the cumulative third quarter ended during the current consolidated fiscal year.」

    The company stated that there were no material changes in its research and development activities and reported cumulative nine-month research and development expenses of ¥693 million.
  28. FY2017-Q2RestatedAnnual report

    「The total research and development expenses of the Group for the cumulative second quarter ended during the current consolidated fiscal year were ¥449 million. By segment, research and development expenses were ¥359 million for the Food Products business and ¥90 million for Prepared Foods. There were no material changes in the status of the Group’s research and development activities during the cumulative second quarter ended during the current consolidated fiscal year.」

    The company stated that there were no material changes in its research and development activities and reported cumulative first-half research and development expenses of ¥449 million.
  29. FY2016First statedAnnual report

    「For spices and herbs, the primary raw materials, the company is working to improve and refine quality through genetic-level analysis and research into breeding and cultivation technologies, with the aim of further ensuring safety and security and maintaining a stable supply. It is also developing applications for a variety of uses and conducting research into the superior functionality that has attracted attention in recent years amid growing interest in natural products and research-oriented approaches.」

    Genetic analysis, breeding and cultivation technologies, application development and functionality research are used to ensure the safety and stable supply of primary raw materials and enhance product value.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
S&B Foods's next results are scheduled for 2026-10-30. Read the earnings preview It last moved in the Revisions to earnings forecasts of 2026-10-30: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.